Neuren Pharmaceuticals Limited (ASX: NEU)
Australia
· Delayed Price · Currency is AUD 19.90
-0.20 (-1.00%)
Jul 3, 2024, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.54 billion as of July 3, 2024.
Market Cap
2.54B
Enterprise Value
2.31B
Revenue
231.93M
Ranking
n/a
PE Ratio
16.61
Stock Price
19.90
Market Cap Chart
Since December 31, 2005, Neuren Pharmaceuticals's market cap has increased from 48.86M to 2.54B, an increase of 5,099.43%. That is a compound annual growth rate of 23.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2024 | 2.54B | -19.45% |
| Dec 31, 2023 | 3.15B | 214.94% |
| Dec 31, 2022 | 1.00B | 125.55% |
| Dec 31, 2021 | 443.99M | 221.49% |
| Dec 31, 2020 | 138.10M | -44.41% |
| Dec 31, 2019 | 248.42M | 79.16% |
| Dec 31, 2018 | 138.65M | -54.31% |
| Dec 31, 2017 | 303.47M | 220.26% |
| Dec 31, 2016 | 94.76M | -50.96% |
| Dec 31, 2015 | 193.24M | 3.73% |
| Dec 31, 2014 | 186.30M | 28.45% |
| Dec 31, 2013 | 145.04M | 252.95% |
| Dec 31, 2012 | 41.09M | 99.01% |
| Dec 31, 2011 | 20.65M | 235.28% |
| Dec 31, 2010 | 6.16M | -38.64% |
| Dec 31, 2009 | 10.04M | 349.57% |
| Dec 31, 2008 | 2.23M | -90.74% |
| Dec 31, 2007 | 24.10M | -45.11% |
| Dec 31, 2006 | 43.91M | -10.14% |
| Dec 31, 2005 | 48.86M | 280.30% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 142.66B |
| ResMed Inc. | 40.85B |
| Cochlear Limited | 21.75B |
| Fisher & Paykel Healthcare Corporation Limited | 16.22B |
| Pro Medicus Limited | 14.96B |
| Sonic Healthcare Limited | 12.63B |
| Ramsay Health Care Limited | 10.86B |
| Telix Pharmaceuticals Limited | 6.23B |